| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/15/2004 | CA2511502A1 1,2,4-triaminobenzene derivatives,useful for treating disorders of the central nervous system |
| 07/15/2004 | CA2511178A1 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/15/2004 | CA2508222A1 Use of thiazolobenzoheterocycles for treating multiple sclerosis |
| 07/15/2004 | CA2453053A1 Use of n2o in the treatment of post-ischemic deterioration of brain cells |
| 07/14/2004 | EP1437592A1 Novel screening method using prokineticin receptor |
| 07/14/2004 | EP1437353A1 Alkyl ether derivatives or salts thereof |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1437133A1 Amines with antialcoholic agents |
| 07/14/2004 | EP1437130A1 Percutaneous absorption preparations |
| 07/14/2004 | EP1437127A1 Suspension comprising oxcarbazepine |
| 07/14/2004 | EP1437043A1 Model animal with overexpression of regucalcin |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436381A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436323A1 Crystal structure of baff, and use thereof in drug design |
| 07/14/2004 | EP1436322A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 07/14/2004 | EP1436318A2 Ncam binding compounds |
| 07/14/2004 | EP1436294A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity |
| 07/14/2004 | EP1436292A1 5-methoxy-8-aryl-[1,2,4]triazolo[1,5-a]pyridine derivatives as adenosine receptor antagonists |
| 07/14/2004 | EP1436290A1 Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor |
| 07/14/2004 | EP1436287A2 Small organic molecule regulators of cell proliferation |
| 07/14/2004 | EP1436273A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 07/14/2004 | EP1436271A1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 07/14/2004 | EP1436270A1 Novel benzothiazine derivatives, their preparation and use |
| 07/14/2004 | EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1436268A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 07/14/2004 | EP1436267A1 Lactam derivatives as antagonists for human 11cby receptors |
| 07/14/2004 | EP1436264A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 07/14/2004 | EP1436258A2 Ph-dependent nmda receptor antagonists |
| 07/14/2004 | EP1436249A2 Muscarinic agonists |
| 07/14/2004 | EP1436247A1 Novel-beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 07/14/2004 | EP1436029A2 Methods and apparatuses for assuring quality and safety of drug administration and medical products and kits |
| 07/14/2004 | EP1436013A2 Method for inducing growth and enhancing survival of nervous tissue |
| 07/14/2004 | EP1436012A2 Polymer conjugates of opioid antagonists |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1435993A2 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/14/2004 | EP1435985A2 Medicament containing activated antithrombin iii |
| 07/14/2004 | EP1435972A2 Novel synthetic ganglioside derivatives and compositions thereof |
| 07/14/2004 | EP1435971A1 Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs) |
| 07/14/2004 | EP1435960A1 Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
| 07/14/2004 | EP1435958A1 Use of phosphorodiesterase iv inhibitors |
| 07/14/2004 | EP1435957A2 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 07/14/2004 | EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/14/2004 | EP1435952A1 8-amino- 1,2,4]triazolo 1,5-a]pyridine-6-carboxylic acid amide |
| 07/14/2004 | EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 07/14/2004 | EP1435950A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435948A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 07/14/2004 | EP1435946A2 Linked biaryl compounds |
| 07/14/2004 | EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 07/14/2004 | EP1435943A2 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug for treating dyskinesia |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435937A2 Composition comprising paracetamol and a bitterness masking component |
| 07/14/2004 | EP1435936A1 5'-carbamoyl-1,1-biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435930A2 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435918A1 Highly compressible ethylcellulose for tableting |
| 07/14/2004 | EP1435917A1 Solid pharmaceutical formulation for a piperazine urea derivative |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1435874A1 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1435787A2 Nestin-expressing hair follicle stem cells |
| 07/14/2004 | EP1235803B1 Urea compounds having muscarinic receptor antagonist activity |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1196170B1 Use of a macrolide compound for the manufacture of a medicament for the treatment of brain damage caused by ischemia or hemorrhage |
| 07/14/2004 | EP1150667B1 Cyclohexenone long-chain alcohol for treating amyotrophic lateral sclerosis |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1140102B1 Triazineone compounds for treating diseases due to neospora and toxoplasma |
| 07/14/2004 | EP1037887B1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 07/14/2004 | EP1017823B1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/14/2004 | EP1014986B1 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT 1 BETA ANTAGONIST OR PARTIAL AGONIST |
| 07/14/2004 | EP0871615B1 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors |
| 07/14/2004 | CN1512995A Novel ligand for nicotinic acety/choline receptors useful in therapy |
| 07/14/2004 | CN1512988A Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 07/14/2004 | CN1512987A Novel 1H-indazole compound |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1512884A 阿立哌唑口服溶液 Aripiprazole Oral Solution |
| 07/14/2004 | CN1512883A Crf受体拮抗剂 Crf receptor antagonist |
| 07/14/2004 | CN1512876A Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 07/14/2004 | CN1511841A Homoeotic box gene 9Brn-1 from quail and its use |
| 07/14/2004 | CN1511837A Intermediate for heterocyclic compound in preparing rotamase inhibitor |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511577A Medicine for treating primary and secondary headache |
| 07/14/2004 | CN1511550A Medicinal preparation for reducing nicotine and use |
| 07/14/2004 | CN1511536A Use of kutkoside-II in nerve cell injury protection |
| 07/14/2004 | CN1511532A Medical composition |
| 07/14/2004 | CN1511525A Application of (+) North America coptisine |
| 07/14/2004 | CN1511520A Use of succinate derivative for biologically treating dementia |
| 07/14/2004 | CN1157392C 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 07/14/2004 | CN1157390C Indole derivant |
| 07/14/2004 | CN1157387C Process for preparing 11-amino-3-chlorine-6, 11-dihydrogen-5, 5-dioxo-6-methyl-dibenzo [c,f][1,2] thiazine and application of synthetic tianeptine |
| 07/14/2004 | CN1157378C Qunoline derivatives |
| 07/14/2004 | CN1157376C Arylpiperidinopropanol and arylpiperaznipropanol derivatives and pharmaceuticals containing the same |
| 07/14/2004 | CN1157371C Monohydrate of cis-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexancecarboxylate |